NBP Latest Headlines

At a glance: stocks gapping up premarket

at seekingalpha.com (Mon, 26-Oct 6:55 AM)

Analyst Reaffirms Buy on NovaBridge Biosciences, Maintains $9 Price Target After Promising Givastomig Phase 1b ESMO 2026 Data

at www.tipranks.com (Mon, 26-Oct 6:45 AM)

NovaBridge Biosciences Positions Givastomig for Phase 3 After Mature ESMO 2026 Data

at www.tipranks.com (Mon, 26-Oct 6:28 AM)

NovaBridge Biosciences Highlights Phase 1 Ragistomig Data at ESMO 2026

at www.tipranks.com (Fri, 23-Oct 9:34 AM)